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Huntington’s disease  (HD)  is  a dominant  inherited neurodegenerative disorder  that  is caused by an unstable expansion of a CAG repeat within the coding region of the IT‐15 gene (HDCRG 1993). The gene encodes for a protein called huntingtin, and the mutation results in an elongated stretch of glutamine near the N‐terminus of the protein (HDCRG 1993). Prevalence of the mutation is 4–10 cases per 100,000 in populations of Western European  descent,  with  many  more  at  risk  of  having  inherited  the  mutant  gene. Overtime,  the  consequence  of  carrying  the  HD  mutation  is  a  massive  brain neurodegeneration  characterized  by  the  prevalent  loss  of  efferent  medium  spiny neurons  in  the  striatum (caudate nucleus and  putamen) of  the basal  ganglia, which  is primarily responsible  for  the  typical HD symptoms  (Reiner et  al 1988). However,  it  is now well established that a more widespread degeneration occurs in the brain and also involves cortical structures (Rosas et al 2005; Rosas et al 2003; Rosas et al 2008). Since HD is caused by a single mutation, the introduction of the mutant gene into non‐human primate, mouse, fly, fish, and worm has generated disease models. This single mutation in huntingtin  is  the  triggering event  that  endows  the protein with new  toxic  functions that are deleterious for brain cells. Although it is well established that the disease occurs as a consequence of an expanded polyQ above 35 and that the polyQ length accounts for the disease onset, some evidence now also points to the loss of physiological activities of the  normal  protein  as  contributing  to  disease  pathogenesis  and,  in  particular,  to  its selectivity.  (Cattaneo et  al 2005; Zuccato et  al 2007). Although a number of molecular dysfunctions have been elucidated and contribute to explain the early deterioration of the spiny‐projection GABAergic neurons of the striatum, the exact mechanisms whereby mutation in huntingtin causes the observed neuronal degeneration, despite a ubiquitous expression, are still unclear. Evidence shows that the pathophysiology of HD may arise both  from  cell  autonomous  processes  within  vulnerable  neurons  and  dysfunction  of interneuronal  interactions,  specifically  at  the  level  of  the  cortical‐striatal  afferents (Cepeda et al 2007; Fan et al 2007; Zuccato et al 2007). 
 
Huntingtin protein Huntingtin  (htt)  is  a  protein  product  of  IT15 gene.  It  is  completely  soluble  protein  of 3,144  amino  acids  (aa)  that  carries  a  polyglutamine  (polyQ)  tract  in  its  N‐terminus. When  this  expands over 36 units,  the protein becomes  toxic and Huntington’s disease (HD) develops. It has many potential domains, the boundaries and activities of which are not fully understood. Huntingtin is expressed ubiquitously in humans and rodents, with 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highest levels in the neurons of the CNS (DiFiglia et al 1995; Ferrante et al 1997; Fusco et al 1999; Trottier et al 1995; Velier et al 1998). Particularly, huntingtin  is eriched  in cortical pyramidal neurons in layers III and V that project to the striatal neurons (Fusco et  al  1999).  Humans  and  rodents  have  two mRNAs  that  are  generated  by  alternative cleavage and polyadenylation of the primary transcript, producing a long and a short 3‐untranslated  region  (UTR)  that differ by 3 kb  (Lin et  al 1993; Li net  al 1994).  In both organisms,  the  long‐UTR  transcript  is  predominantly  expressed  in  the  brain, whereas the  short‐UTR  transcript  is  more  widely  expressed  (Lin  et  al  1993).  Intracellularly, mammalian huntingtin is associated with a variety of organelles, including the nucleus, endoplasmic reticulum, Golgi complex, and mitochondrion (Hilditch‐Maguire et al 2000; Hoffner et  al 2002; Kegel  et  al 2002; Panov et  al 2002,  Strehlow et  al 2007).  It  is  also found  within  neurites  and  at  synapses,  where  it  associates  with  various  vesicular structures  such  as  clathrin‐coated  vesicles,  endosomal  compartments  or  caveolae,  as well  as  microtubules  (DiFiglia  et  al  1995;  Hilditch‐Maguire  et  al  2000;  Hoffner  et  al 2002; Velier et al 1998). This widespread subcellular localization does not facilitate the definition of its function 
 
Huntingtin protein structure The  primary  amino  acid  sequence  of  huntingtin  reveals  little,  as  there  are  only  a  few known  sequence motifs  and  no  structural  domains with  defined  functions  (Figure  1). One  obviously  important  portion  of  the mammalian  protein  is  the  polyQ  region  itself, which is also present in many transcription factors and aberrantly expanded in at least eight other disease‐causing proteins (Everett et al 2004). Because each of these diseases is characterized by the loss of a specific subset of neurons, it is previously proposed that sequences around the glutamine tract might have a crucial role in disease pathogenesis (Cattaneo et  al 2001). The polyQ stretch  in huntingtin begins at  the eighteenth amino acid, and, in unaffected individuals, contains up to 34 glutamine residues (HDCRG 1993). In  1994,  Perutz  et  al.  showed  that  this  portion  forms  a  polar  zipper  structure,  and suggested  that  its physiological  function  is  to bind  transcription  factors  that  contain a polyQ  region  (Perutz  et  al  1994);  it  has  now  been  shown  that  wild‐type  huntingtin interacts  with  several  partners  and  that  the  polyQ  tract  is  a  key  regulator  of  such binding  (Harjes and Wanker 2003; Li  and Li 2004; Goehler at  al 2004). Clabough and collegues  have  generated mice with  a  precise  deletion  of  the  short  CAG  triplet  repeat encoding 7Q in the mouse HD gene Hdh (DeltaQ/DeltaQ). Hdh (DeltaQ/DeltaQ) mice are 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born with normal Mendelian frequency and exhibit only subtle phenotypes, i.e., defects in learning and memory test. The authors suggest that the polyQ tract is not required for essential  function  of  huntingtin  but  instead  may  modulate  a  normal  function  of  the protein.  In  higher  vertebrates,  the  polyQ  region  is  followed  by  a  polyproline  (polyP) stretch,  which  might  help  to  keep  the  protein  in  solution  (Clabough  et  al  2006). Downstream of these regions are the so‐called HEAT repeats, which are~40‐amino‐acid‐long  sequences  that  occur  multiple  times  within  a  given  protein  and  are  involved  in protein–protein  interactions  (Andrade  and  Bork  1995;  Neuwald  and  Hirano  2000). Bioinformatic analyses have found 36 putative HEAT repeats in huntingtin (Takano and Gusella  2002).  Subsequently,  three main  clusters  of  HEATs  have  been  identified.  The repeats are well conserved in huntingtin from all vertebrates, which may indicate that it interacts  with  the  same  proteins  across  vertebrates,  whereas  28  putative  consensus repeats  have  been  found  in  Drosophila  melanogaster  huntingtin,  whose  degree  of conservation with respect to humans has yet to be fully defined. In 2001, Andrade et al. (Andrade  et  al  2001)  reported  that  HEAT  repeats  could  be  organized  in  three‐dimensional  structures  called  ROD.  More  recently,  a  new  neural  network  for  the prediction of rod repeats has been applied to huntingtin, and three domains of ROD have been  found  that  defined  H1  covering  from  amino  acids  114  to  413,  H2  comprised between 672 and 969, and H3 between 2667and 2938 (Palidwor et al 2009). The study revealed  also  for  the  first  time  the  presence  of  intra  molecular  interactions  between single  RODs  of  human  huntingtin,  suggesting  the  possibility  of  homodimerization  of huntingtin  through  inter‐  and  intramolecular  association  of  the  RODs  domain.  The presence of HEAT repeats suggests that huntingtin may exert its physiological function by using different protein partners. Huntingtin  contains  a  functionally  active  carboxy  (C)‐terminal  nuclear  export  signal (NES) sequence and a less active nuclear localization signal (NLS), which might indicate that  the  protein  (or  a  portion  of  it)  is  involved  in  transporting  molecules  from  the nucleus to the cytoplasm (Xia et al 2003). This hypothesis is supported by huntingtin’s perinuclear and nuclear distribution,  and  the  recent demonstration  that  the 17 amino acids before the polyQ region interacts with the nuclear pore protein TPR (translocated promoter  region),  which  exports  proteins  from  the  nucleus.  Removal  of  these  amino acids  causes  huntingtin  to  accumulate  in  the nucleus  (Cornett  et  al  2005). Huntingtin also contains three well‐characterized protease cleavage consensus sites (Goldberg et al 1996; Wellingtonet al 1998; Wellington et al 2000; Gafni and Ellerby 2002; Gafni et al 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2004),  where  cleavage  generally  leads  to  fragments  of  both  normal  and  mutant huntingtin,  although  the  latter  is  more  susceptible  to  proteolysis  and  generates fragments that are found in the cytoplasm and nucleus (Davies et al 1997; DiFiglia et al. 1997; Kim et al 2002; Lunkes et al 202; Wellington et al 2002). Caspase cleavage sites are  typically  conserved  in  vertebrate  huntingtin,  but  not  in  that  of  D.  melanogaster (Goldberg et al 1996; Wellingtonet al 1998; Wellington et al 2000; Wellington et al 2002; Li et al 1999). Functionally active calpain cleavage sites have been described for mouse and human huntingtin (Gafni and Ellerby 2002; Gafni et al 2004). Other sites, the exact amino acid positions of which are not well defined,  are preferentially  cleaved  in  some brain regions (Mendle‐Mueller et al 2001). The contribution of huntingtin proteolysis to cell  function  is  unclear.  However, modifications  in  the  activity  of  caspase  and  calpain reduce the proteolysis and toxicity of the mutant protein, and delay disease progression (Wellington et al 2000; Gafni et al 2004; Ona et al 1999). Huntingtin  is subject  to  four types of post‐translational modification: the amino (N)‐terminal lysines K6, K9 and K15 compete  for  sumoylation  and  ubiquitination  (Steffan  et  al  2004; Kalchman 1996)  and phosphorylation at serines 421 and 434 influences cleavage and toxicity, and is reduced in HD  (Humbert  et  al  2002; Warby  et  al  2005;  Luo  et  al  2005; Hackman  et  al  2000). Huntingtin  is  also  palmitoylated  by  its  co‐partner,  huntingtin‐interacting  protein  14 (HIP14,  a  palmitoyl  transferase),  but  the  precise  amino  acid  position  involved  is unknown.  The  palmitoylation  of  huntingtin  is  consistent  with  its  proposed  role  in regulating vesicular trafficking, because palmitoylated proteins are often involved in the dynamic  assembly  of  components  that  control  vesicle  trafficking  and  synaptic  vesicle function  (Huang  et  al  2004;  DiFiglia  et  al  1995).  Therefore,  huntingtin  might  have flexible  or multifunctional  structures  capable  of  assuming  specific  conformations  and activities depending on its binding partners, subcellular location, and time of maturation in  a  given  cell  type  and  tissue.  Recently  Bezprozvanny  and  colleagues  used  X‐ray crystallography  at  atomic  resolution  to  show  that  polyglutamine  in  huntingtin  adopts multiple  flexible  conformations  (  ‐helix,  random  coil,  and  extended  loop)  (Kim  et  al 2009).   
Huntingtin Functions (Figure 2) 
Huntingtin in embryonic development. Two years after the cloning of the gene, huntingtin was  shown  to  be  essential  for  embryonic  development  as  its  complete  inactivation  in huntingtin knock‐out mice (Hdh‐/‐ ) causes embryonal death before day 8.5, i.e., before 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gastrulation and the formation of the nervous system (Duyao et al 1995; Nasir et al1995; Zeitlin  et  al  1995).  The  basis  of  this  effect  appears  to  be  increased  apoptosis  in  the embryonic ectoderm shortly after the onset of gastrulation. It is known that the defect in development observed in the huntingtin knock‐out mice embryos derives from a defect in the organization of extraembryonic tissue, possibly as a consequence of an alteration in the nutritive function of the visceral endoderm (Dragatsis et al 1998). Intriguingly, the inactivation of huntingtin gene does not reveal a phenotype in Drosophila melanogaster embryos,  further  reinforcing  the  evidence  that  the  protein  in  the  protostome  branch may have different functions (Zhang et al 2009). Unexpectedly, Drosophila huntingtin is required  for maintaining the mobility and  long‐term survival of adult animals, and for modulating axonal  terminal complexity  in  the adult brain (Zhang et al 2009). With the progression of embryonic development, experimental reductions of huntingtin levels to below 50% cause defects  in  the epiblast,  the structure that will give rise  to  the neural tube,  and profound cortical  and  striatal  architectural  anomalies  (Auerbach et  al 2001; White et al 1997). Defects in the formation of most of the anterior regions of the neural plate, specifically in the formation of telencephalic progenitor cells and the preplacodal tissue,  have  been  recently  found  by  Henshall  et  al.  (Henshall  et  al  2009)  that  used morpholinos to reduce huntingtin levels in the developing zebrafish. These data indicate that,  in  addition  to  its  early  extraembryonic  function,  at  post  gastrulation  stages huntingtin  participates  in  the  formation  of  the  CNS.  To  further  investigate  the  role  of huntingtin  in  development,  Dragatsis  and  colleagues  (Dietrich  et  al  2009)  have inactivated  the  Hdh  gene  in  Wnt1  cell  lineages  using  the  Cre  loxP  system  of recombination,  demonstrating  that  conditional  inactivation  of  the  Hdh  gene  in  the midbrain  and  hindbrain  results  in  congenital  hydrocephalus.  These  results  implicate huntingtin also in the regulation of cerebralspinal fluid (CSF) homeostasis (Dietrich et al 2009).  Analyses  of  chimeras  created  by  blastocyst  injectionof  Hdh  ‐/‐ES  cells  have provided  further  insights  into  the  role  of wild‐type  huntingtin  in  brain maturation  by showing that it is critical for establishing and maintaining especially cortical and striatal neuronal identity (Reiner et al 2001). Although some brain regions were appropriately colonized by Hdh  ‐/‐neurons,  few donor  cells were  found  in  cerebral  cortex,  striatum, basal  ganglia,  thalamus,  and  the  Purkinje  cell  layer  of  the  cerebellum,  thus  suggesting that  huntingtin  plays  a  specific  role  in  neuronal  survival  in  these  brain  regions. Preliminary analyses of blastocysts injected chimeras at E12.5 showed ongoing Hdh ‐/‐ cell  degeneration  specific  to  the  striatum,  cortex,  and  thalamus,  thus  supporting  the 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view  that  neuroblasts  in  these  areas  need  to  synthesize  huntingtin  if  they  are  to progress  in  development  and  differentiation  (Reiner  et  al  2003).  These  data  indicate that huntingtin is required at different steps of embryonic development and that its total absence or  50% reduced presence generates a very early phenotype in mice. Moreover, the HD mutation does not seem to abrogate the developmental functions of huntingtin, as  HD  patients  pass  development  and  symptoms  only  start  to manifest  several  years after  birth. Human mutant  huntingtin  can  compensate  for  the  absence  of  endogenous huntingtin,  by  rescuing  the  embryonic  lethality  of  mice  homozygous  for  a  targeted disruption  of  the  endogenous Hdh  gene  (Leavitt  et  al  2001).  Thus  it  is  reasonable  to suggest that huntingtin’s function during embryonic development is independent of the length of the polyQ. Mice carrying 50% full‐length wild‐type huntingtin (i.e., one allelic dose)  reach  normal  adult  life  (Duyao  et  al  1995;  Nasir  et  al1995;  Zeitlin  et  al  1995). However, one of  three generated heterozygous knock‐out mice, which still expresses a 20‐kDa  N‐terminal  portion  of  wild‐type  huntingtin,  at  adulthood  shows  behavioral abnormalities,  cognitive  deficits,  and  significant  neuronal  loss  in  the  subthalamic nucleus  (Nasir  et  al  1995;  O’Kusky  et  al  1999).  This  phenotype  may  be  ascribed  to reduced  huntingtin  function(s)  and/or  to  a  dominant  negative  effect  driven  by  the remaining N‐terminal fragment over the full‐length wild‐type protein, regardless of the CAG  tract.  Although HD mice  are  born with  no  apparent  defects,  a  recent  study  from Mehler’s  group  suggests  that  developmental  abnormalities  occur  in  a  knock‐in mouse model  of  HD  (HdhQ111)  compared with  a  knock‐in mouse model  expressing  only  18 CAG  (HdhQ18)  (Molero  et  al  2009).  By  analyzing  the  expression  of markers  of MSNs such as Islet1, dopamine and cAMP‐regulated phosphoprotein, 32‐kDa (DARPP32), and mGluR1  in  the  striatum  of  HdhQ111  embryos  at  E17.5,  the  authors  report  an impairment  in  the  acquisition  of  the  cytoarchitecture  of  striatal  subcompartments, suggesting  abnormalities  in  MSN  specification  and  maturation.  They  also  show  that neural  progenitor  cells  from  embryonic  striatum  exhibit  in  vitro  reduced proliferative potential, enhanced  late‐stage  self‐renewal,  and  impaired generation of MSN subtypes. Yet,  HdhQ111  mice  show  a  very  mild  disease  phenotype  and  no  striatal  neurons degeneration.  Although  more  work  is  required,  the  hypothesis  that  HD  may  be  a developmental disease is of interest, especially given that recent preliminary functional MRI analyses  (fMRI)  studies  indicate  that  subtle brain  structure abnormalities may be present  in  children  at  risk  for  HD  (age  7–18) who  are  estimated  to  be  decades  from diagnosis and may be indicative of developmental defects (Nopoulos et al 2009). More 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recently, Godin and colleagues has found that inactivation of the mouse huntingtin gene in  neural  progenitor  promotes  neurogenesis,  induced  premature  differentiation  and alter  cell  fate  of  cortical  progenitors  by  mechanisms  involving  mitotic  spindle orientation (Godin et al., 2010).  
Huntingtin  in  adult  brain.  In  vitro  and  in  vivo  studies  have  shown  that  wild‐type huntingtin has a pro‐survival  role. The  first  in  vitro  demonstration of  an antiapoptotic role  of  wild‐type  huntingtin  came  from  experiments  performed  by  our  group  on immortalized cell lines. We found that overexpression of wild‐type huntingtin in brain‐derived cells protects  them  from  toxic  stimuli  (Rigamonti  et  al 2000; 2001). One year later, similar results have been obtained by Rubinsztein and colleagues (Ho et al 2001) who showed that wild‐type huntingtin can protect neuroblastoma and kidney cell lines from death triggered by the mutant protein. Additional confirmation of an antiapoptotic role  of  huntingtin  came  from  studies  by  Hayden’s  group.  They  found  that  primary striatal  neurons  from  YAC18  transgenic  mice  overexpressing  full‐length  wild‐type human  huntingtin  were  protected  from  apoptosis  compared  with  cultured  striatal neurons  from  non  transgenic  littermates  and  YAC72  mice  expressing  mutant  human huntingtin  (Leavitt  et  al 2006). On  the  contrary,  cells depleted of wild‐type huntingtin were more  sensitive  to  apoptotic  cell  death  and  showed  increased  level  of  caspase‐3 activity, with  respect  to  control  cells  (Zhang  et  al  2006).  Some  of  the mechanisms  by which  wild‐type  huntingtin  protects  cells  from  apoptotic  cell  death  have  been elucidated.  We  found  that  wild‐type  huntingtin  blocks  the  formation  of  a  functional apoptosome  complex  and  the  consequent  activation  of  caspase‐3  and  caspase‐9 (Rigamonti et al 2000; 2001). In line with these findings, a study from Friedlander and colleagues  (Zhang  et  al  2006)  showed  that  wild‐type  huntingtin  blocks  apoptosis  by physically  interacting with  active  caspase‐3,  thereby  inhibiting  its  proteolytic  activity. Other authors  found  that huntingtin  inhibits  the  formation of  the proapoptotic HIPPI‐HIP1  complex,  thus  interfering  with  procaspase‐8  activation  and  apoptotic  cell  death (Gervais  et  al  2002;  Hackam  et  al  2000).  Further  studies  revealed  that  wild‐type huntingtin  is  a  substrate  for Akt,  a  serine/threonine kinase  that  activates pro‐survival pathways, and may participate in the phosphoinositide3‐kinase (PI3K)‐Akt pathway by stimulating  the  expression  of  prosurvival  genes, whereas  death  genes  such  as BAX  or Bcl‐2 are repressed (Rangone et al 2004). In 2000 Zeitlin’s group showed that neuronal inactivation of  the huntingtin gene  in adult mice by means of  a Cre/LoxP  site‐specific recombination  system  driven  by  the  neuronal‐specific    subunit  of  the  calcium‐
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dependent  calmodulin  kinase‐2  (Camk2a)  promoter,  causes  apoptotic  cells  in  the hippocampus,  cortex,  and  striatum,  and  a  lack  of  axon  fibers  (Dragatsis  et  al  2000, Rigamonti  et  al  2000).  This  animal model  showed  a  progressively more  severe  limb‐clasping  upon‐tail  suspension  phenotype,  a  feature  also  observed  in  transgenic  HD mouse mutants. Further studies provided in vivo evidence that huntingtin regulates the balance between neuronal survival and death and that the levels of huntingtin modulate neuronal  sensitivity  to  excitotoxic  neurodegeneration  (Leavitt  et  al  2006).  In  fact,  the overexpression of wild  type huntingtin  in YAC18  transgenic mice was  found  to  confer significant protection against apoptosis  triggered by excitotoxicity (Leavitt et al 2006). Moreover,  endogenous  huntingtin  is  reduced  following  ischemic  injury  through  a caspase mediated  process,  while  overexpression  of wild‐type  huntingtin  two  to  three times  with  respect  to  levels  in  wild  type  mice  protects  against  ischemic  injury  in  an huntingtin dose‐dependent manner (Zhang et al 2003). More recently, the antiapoptotic role of huntingtin has been highlighted also in non mammalian models. In fact, apoptotic cell death has been  found  in zebrafish embryos  in which huntingtin has been knocked down  by  morpholino  technology  (Diekmann  et  al  2009).  Huntingtin  morpholino‐injected  zebrafish  showed  a massively  increased  cell  death  as  indicated  by  caspase‐3 activity especially in the midbrain/hindbrain region of the developing zebrafish embryo. This  increased  apoptosis was  accompanied by a  severe underdevelopment of  the CNS (Diekmann et al 2009). 
Huntingtin and gene  transcription. Biological  and molecular  findings have  linked wild‐type huntingtin to BDNF, a neurotrophin that is particularly important for the survival of striatal neurons and for the activity of the cortico‐striatal synapses (Zuccato et al 2007). BDNF colocalizes with huntingtin  in  cortical neurons  that project  to  the  striatum and, despite  some reports of BDNF mRNA  transcription  in adult  striatal neurons,  it  is well established  that  most  of  the  striatal  BDNF  is  produced  in  the  cerebral  cortex  and delivered  to  the  striatal  neurons  via  the  cortico‐striatal  afferents  (Altar  et  al  1997; Baquet  et  al  2004;  Fusco  et  al  1999).  Several  findings  have  led  to  the  conclusion  that wild‐type huntingtin contributes to the pool of BDNF proteins produced in the cerebral cortex  and  that  a  loss  or  reduction  in wild‐type  huntingtin  activity  diminishes  BDNF production  and  delivery  to  striatal  targets,  thus  likely  contributing  to  selective degeneration  of  those  neurons  (Zuccato  et  al  2007;  2001;  2008;  2003;  Gauthier  et  al 2004). Wild‐type  huntingtin  stimulates  cortical  BDNF protein  production  by  acting  at the  level  of  BDNF  gene  transcription  as  shown  by  in  vitro  and  in  vivo  data.  In  fact, 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cultured  brain  cells  overexpressing  wild‐type  huntingtin  produce  increased  BDNF mRNA  and  protein  levels.  Studies  on  YAC mice  expressing  increased  full‐length  wild type  huntingtin  levels  (YAC18)  also  show  high  BDNF  protein  levels  in  the  cerebral cortex, as a consequence of the positive regulation by wild‐type huntingtin of the BDNF gene transcription (Zuccato et al 2001). Therefore, higher striatal BDNF levels are found in the mice (Zuccato et al 2001). Conversely, reduced BDNF mRNA levels are  found  in brain  samples  from  wild‐type  huntingtin‐depleted  mice  as  well  as  in  heterozygous huntingtin knock‐out mice (Zuccato et al 2007; 2003). A similar 50% BDNF reduction is found  in  whole  zebrafish  embryos  in  which  huntingtin  has  been  knocked  down (Diekmann  et  al  2009).  A more  thorough  assessment  of  the molecular mechanism by which wild‐type huntingtin affects BDNF gene transcription has shown that the normal protein  specifically  regulates  the  activity  of  one  of  the  BDNF  II  promoters.  The investigation  of  the  mechanism  by  which  wildtype  huntingtin  stimulates  BDNF  gene transcription has concentrated on BDNF promoter exon II, within which a conserved 21‐ to  23‐bp  DNA  response  element  (RE1/NRSE)  is  recognized  by  REST/NRSF transcriptional regulator. REST/NRSF was identified in 1995 as a protein that binds the RE1/NRSE silencing sequences present in the rat Scn2a2 and Stmn2 (SCG10) genes. We have found that the RE1/NRSE silencing activity is inhibited in the presence of wild‐type huntingtin,  through  recruitment  and  sequestration  of  REST/NRSF  into  the  cytoplasm; REST/NRSF  is  therefore  prevented  from  binding  to,  and  activating,  the  nuclear RE1/NRSE regulatory elements. Huntingtin does not seem to interact with REST/NRSF directly, but rather seems to be part of a complex that contains HAP1 and RILP, a protein that  directly  binds  REST/NRSF  and  promotes  its  nuclear  translocation  (Shimojo  et  al 2008).  Huntingtin may  therefore  act  in  the  nervous  system  as  a  general  facilitator  of neuronal gene transcription for a subclass of genes. 
Huntingtin role in axonal and vesicle transport. Huntingtin is found predominantly in the cytoplasm  of  neurons  and  is  enriched  in  compartments  containing  vesicle‐associated proteins (Velier et al 1998). In line with this finding, it is retrogradely transported in the rat sciatic nerve where it associates with vesicles and microtubules (Block‐Galarza et al 1997). Further evidence of  a  role of huntingtin  in  intracellular  transport  came  from a study  by  Goldstein’s  group  (Gunawardena  et  al  2003).  They  found  that  reduction  in 
Drosophila huntingtin  disrupts  axonal  transport  (Gunawardena  et  al  2003). Wild‐type huntingtin  is  also  involved  in  fast  axonal  trafficking  of  mitochondria  in  mammalian neurons (Trushina et al 2004). In primary striatal neurons taken from mice expressing 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only  one  copy  of  the  wildtype  allele  or    50%  of  normal  huntingtin  levels  upon  CRE‐mediated recombination (knock‐out), mitochondria became progressively  immobilized (Trushina  et  al  2004).  This  effect  was  significantly  stronger  in  complete  knock‐out neurons than in those with a 50% loss of huntingtin, which points to a dose‐dependent effect. Several reports  indicate that wild type huntingtin regulates axonal  transport by participating  in  the  assembly  of  the  motor  complex  on  microtubules.  It  has  been proposed  that  huntingtin  associates with motor  proteins  via HAP1,  a  protein  that has been shown to interact with both huntingtin and the p150 subunit of dynactin, thereby enabling  retrograde  transport  and perhaps anterograde  transport  (Gunawardena et  al 2005).  Further  evidence  implicating  huntingtin,  HAP1,  and  p150(glued)  comes  from studies that have highlighted huntingtin’s role in the control of BDNF vesicle transport (Gauthier et al 2004).  
Huntingtin and synaptic activity. Normal communication between neurons  is regulated by a number of proteins  in  the  synapse. Normal huntingtin  interacts with  cytoskeletal and  synaptic  vesicles  proteins  essential  for  exo‐  and  endocytosis  at  the  synaptic terminals,  thus participating  in  the  control of synaptic  activity  in neurons  (Smith et  al 2005). One early finding shows that wild‐type huntingtin directly binds the SH3domains of  PSD95  (Sun  et  al  2001).  PSD95  is  a  key  molecule  in  synaptic  transmission  and  a component of the membrane associated guanylate kinase (MAGUK) protein family that binds the NMDA and kainate receptors at the postsynaptic density (Maue et al 1990). A decreased  interaction  of  mutant  huntingtin  with  PSD95  has  been  described  in  HD, suggesting  that  more  PSD95  is  released  in  HD,  thus  affecting  the  activity  of  NMDA receptors,  and  possibly  leading  to  their  overactivation/sensitization  and  to excitotoxicity (Sun et al 2001). More recent data show that huntingtin may also take part in  the presynaptic complex through  its  interaction with HIP1, which has been recently associated with  the presynaptic  terminal  (Parker et  al 2007). Furthermore, huntingtin can bind to PACSIN1/syndapin, syntaxin, and endophilin A, which collectively play a key role  in  synaptic  transmission,  as  well  as  in  synaptic  vesicles  and  receptor  recycling. These interactions depend on the length of the polyglutamine repeat and are enhanced by the presence of an expanded CAG, leading to impairment of synaptic transmission in HD (Smith et al 2005). 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Huntingtin Through Evolution  Most  of  the  known  huntingtin  protein  homologues  belong  to  vertebrates  and  show  a high degree of  conservation  throughout  their  length,  as murine huntingtin homologue with  a  86%  of  similarity.  All  mammalian  huntingtin  homologues  shared  an  high conserved  sequences, while  high  differences  are  concentrated  in  polyQ  tract.  In  1996 Pecheux and co‐authors studied huntingtin homologues in different mammalian species, among  other  gorilla,  pig  and  dog.  In  particular  the  study  is  focused  on  the  region  of huntingtin  that  contained  the  polyQ.  In  all  investigated  species,  the  number  of  CAG found  is  equal  or  inferior  to  the  normal  range  of  human  IT15  alleles.  The  longer uninterrupted CAG stretch was found in the pig and consists of 18 CAG. Interestingly in all these species the CAG tract is interrupted by a CAA triplet that encoded for glutamine. This  interruption  could  lead  a  more  stably  polyQ  tract  (Pecheux  et  al  1996).  The huntingtin  sequence  is  well  conserved  also  in  vertebrate  as  zebrafish  homologue  of huntingtin  protein  has  79%  of  homology  sequence with  4  glutamine  (Karlovich  et  al. 1998).  The  most  divergent  vertebrate  species  (i.e., Homo  sapiens  and  the  Fugu  fish) show 80% conservation.  Interestingly, because of  the presence of  shorter  introns,  the 
Fugu  gene  contains  67  exons  as  the  human  gene,  but  it  spans  over  a  region  of  22kb (Sathasivam et al 1997).  The  only  entirely  known  invertebrate  amino  acid  sequence  is  from  Drosophila 
melanogaster,  in  the  protostome  branch,  which  is  characterized  by  five  20–50% conserved regions distributed throughout the length of the protein (Li et al 1999; Zhang et al 2009). We therefore speculated that Drosophila huntingtin represents a residue of the  ancestral  huntingtin  molecule  at  the  origin  of  the  protostoma‐deuterostoma branches, suggesting that huntingtin is, evolutionarily, an old gene (Cattaneo et al 2005). In  line with this hypothesis, huntingtin  is present  in an old deuterostome,  the tunicata 
Halocynthia  roretzi  (sea  pineapple)  and  in  the  echinodermata  Heliocidaris 
herithrogramma  (sea  urchin)  (Kauffman  et  al  2003).  More  recently,  work  from Andrade's group has predicted the presence of the protein in ancient organisms such as the  amoeba  Dyctostelium  discoideum  and  nematode  C.  elegans,  but  not  in  the 
Saccharomyces cerevisiae or in previously divergent plants, thus confirming the ancient origin of huntingtin (Palidwor et al 2009). The analysis of huntingtin tissue distribution in species of the phylogenetic tree lead to interesting  information  from  the  expression  of  the  huntingtin  gene  in  two  basal deuterostomes. Deuterostomes consist of two primary clades: one, the chordates, which 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contains  the  ascidian,  cephalochordates,  and  vertebrates;  and  a  second  clade,  which contains the hemichordates and echinoderms. Preliminary analyses of huntingtin mRNA expression  and  distribution  in  the  primitive  chordate Halocynthia  roretzi  and  in  the echinoderm Heliocidaris herithrogramma (sea urchin) detected huntingtin mRNA at all stages of development. Interestingly, C‐terminal huntingtin sequence seems confined to non  neural  tissues  in  the  echinoderm  Heliocidaris  herithrogramma.  On  the  contrary, huntingtin  has  a  ubiquitous  distribution  in  the  primitive  chordate Halocynthia  roretzi with  increased  levels of expression  in the nervous system.  In ancestral deuterostomes, the huntingtin expression pattern is prevalently non neural and that neural expression of  the  HD  gene may  be  a  chordate  evolutionary  novelty  (Kauffman  et  al  2003). More recently,  we  have  investigated  huntingtin  expression  during  development  of  the cephalochordate  lancelet  (Branchiostoma  floridae)  (Candiani  et  al  2007).  The development  of  the  nervous  system  of  lancelet  is  in  fact  particularly  close  to  that  of vertebrates  as  it  includes  vertebrate‐like  anatomical  characteristics  such  as cephalization and a dorsal nerve cord. We found that in lancelet, huntingtin expression is detectable by  in  situ hybridization starting  from the early neurula stage, where  it  is found in cells of the neural plate. At later stages, it is retained in the neural compartment but also it appears in limited and well defined groups of non neural cells. At subsequent larval  stages,  huntingtin  expression  is  detected  in  the  neural  tube,  with  the  strongest signal being present  in  the most anterior part (Candiani et al 2007). This study shows for the first time a subregionalization of huntingtin’s expression in the nervous system (Candiani  et  al  2007).  When  huntingtin  distribution  has  been  analyzed  in  the protostome branch,  in  the divergent organism Drosophila melanogaster,  an ubiquitous expression  of  huntingtin  has  been  revealed  (Li  et  al  1999;  Zhang  et  al  2009). Furthermore, when huntingtin has been genetically inactivated in Drosophila, the larva developed without any defect in the gastrulation process, suggesting that, in contrast to what  happens  in  the  deuterostome  branch,  the  protein  is  not  involved  in  controlling embryo development (Cattaneo et al 2005). 
 
Loss of Wild­Type Huntingtin Function in HD The above data indicate that wild‐type huntingtin has beneficial activities in the mature brain. It is therefore possible that its loss in human HD reduces the ability of neurons to survive and to counteract the toxic effects of the mutant protein. In some mouse models, homozygosity  for  the  HD  mutation  leads  to  a  more  severe  phenotype  than 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heterozygosity  for  an  equivalent  CAG  expansion  in  the HD  gene  (Wheleer  et  al  1999; Reddy  et  al  1998).  Similarly,  a  small  cohort  of  HD  patients  homozygous  for  the  CAG expansion  seems  to  show  a  more  severe  disease  progression  than  those  who  were heterozygous for the mutation (Squitieri et al 2003). Further studies in lymphoblastoid cell lines revealed that homozygotes have a more aggressive molecular phenotype than heterozygotes (Maglione et al 2006, Squitieri et al 2006).  Hayden's group demonstrated the in vivo contribution of the loss of wild‐type huntingtin function  in  HD.  YAC128  mice  were  initially  crossed  with  mice  heterozygous  for  the targeted  inactivation  of  the  mouse  HD  gene  (Hdh+/‐mice)  to  generate  YAC128  mice heterozygous for the targeted inactivation of Hdh (YAC128 +/‐). These mice were then crossed  with  Hdh  +/‐  mice  to  generate  YAC128  mice  homozygous  for  the  targeted inactivation  of Hdh  (YAC128  ‐/‐  mice)  (Van  Raamsdonk  et  al  2005).  The  phenotypic severity  of  YAC128  +/+ mice  (carrying  extra  copies  of  mutant  huntingtin  with  128Q repeats in normal huntingtin background) was compared with that observed in double mutant  YAC128‐/‐  mice  that  do  not  express  endogenous  wild‐type  huntingtin  but express the same amount of  the mutant protein with 128Q. The complete loss of wild‐type huntingtin in the YAC128 ‐/‐ mice led to a slight worsening of striatal atrophy and neuronal loss and a small but significant decrease in the neuronal cross‐sectional area. YAC128 ‐/‐ mice also showed behavioral and motor abnormalities. In addition, testicular atrophy  and  degeneration  were  markedly  worsened  in  the  absence  of  wild‐type huntingtin. These data suggest that the elimination of wild‐type huntingtin expression in YAC128 mice results in the exacerbation of behavioral deficits and survival, with a mild worsening  of  neuropathology.  The  absence  of  severe  striatal  abnormalities  led  to  the suggestion  that  the  striatal  phenotype  is  primarily  dependent  on  mutant  huntingtin toxicity. Considering a different experimental approach with non mammalian models of HD, Zhang et al. (Zhang et al 2009) have recently shown that the removal of endogenous 
Drosophila  huntingtin  significantly  accelerates  the  neurodegenerative  phenotype associated  with  a  Drosophila  model  of  polyglutamine  huntingtin  toxicity  (HD‐Q93), further suggesting that disrupting the normal function of huntingtin might contribute to HD pathogenesis. Several studies have evaluated the impact of wild type huntingtin overexpression in HD. In 2001, Hayden’s team showed that expression of mutant huntingtin in the absence of wild‐type huntingtin results  in massive apoptotic cell death  in  the testes of male mice, but  that  the  observed  cell  death  can  be  modulated  by  the  expression  of  normal 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huntingtin.  In  fact,  no  evidence  of  apoptosis  is  seen  in  the  testes  of  mice  expressing human  mutant  huntingtin  when  endogenous  wild‐type  huntingtin  is  expressed  from both  Hdh  alleles  (Leavitt  etal  2001).  These  data  indicate  that  wild‐type  huntingtin reduces  the  cellular  toxicity of mutant huntingtin  in  vivo  in  the  testes of mice  (Leavitt etal 2001). Similar results were obtained in in vitro experiments involving non neuronal cells,  showing  that  overexpression  of wild‐type  huntingtin  reduces  the  polyQ  toxicity induced  by  an  exogenous  mutant  huntingtin  construct  (Ho  et  al  2001).  Moreover, overexpression  of  wild‐type  huntingtin  rescued  the  activity  of  a  tk‐RE1/NRSE‐cat construct  in109/7Q  knock‐in  cells,  indicating  that  the  wild‐type  protein  inhibits  the silencing  activity  of  the  RE1/NRSE  and  promotes  BDNF  gene  transcription  in  HD (Zuccato  et  al  2003).  Similarly,  the  expression  of  wild‐type  huntingtin  in  109/109Q knock‐in cells seems to be able to rescue the decreased transport and release of BDNF, although the number of analyzed cells was a limiting factor in the experiment (Gauthier et al 2003). However, one should expect that higher levels of wild‐type huntingtin may be required to overcome the dysfunctions caused by mutant huntingtin.   
Mouse Embryonic Stem cells Mouse embryonic  stem (ES)  cells  are permanent  cell  lines derived  from  the  inner  cell mass  of  blastocyst  (Evans  and  Kaufman,  1981;  Martin,  1981).  These  cells  have  three main hallmarks: they undergo symmetrical self‐renewing divisions, they are pluripotent with  capacity  to  differentiate  into  all  fetal  and  adult  cell  lineages,  and  they  can incorporate  into embryos and contribute to  functional  tissue generation (Smith 2001). ES  cells  are  commonly  cultured  in  in  the  presence  of  feeder  layer  (MEF‐Murine Embryonic  Fibroblast),  with  bovine  serum  (as  BMP4  source)  and  LIF  (Leukemia inhibitory factor). The feeder layer is used as a source of LIF and as a trophic support, but  in  the presence of serum and LIF ES cells are able  to maintained self‐renewal also plated on gelatin coating, without feeder. LIF and BMP4 source are able to sustain self‐renewal through the inhibition of differentiation stimuli. LIF, is a cytokine that acts with its receptor LIFR activating Stat3 pathway, preventing ES cells endoderm differentiation. BMP4, a member of TGFβ family, bind its receptor and activates Smad signal. This causes the  activation  of  Id  (inhibition  of  differentiation  )  genes  transcription  and  prevents trophoectoderm  differentiation,  promoting  plurypotency.  Recent  studies  have demonstrated  that  self‐renewal  conditions  are well  preserved  in  serum  free media  in the presence of ERK and GSK3β  inhibitors (Ying 2008 et al, Wray et al 2010). Ying and 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1. A bioinformatic study to reveal huntingtin putative domains In  the  first  part  of  my  PhD  project  I  contributed  to  a  bioinformatic  study  about huntingtin  primary  sequence.  The  aim  of  this  study  was  to  reconstruct  huntingtin evolution  to better understand  the  structure and  its particular  subdivision  in possible protein  domains.  We  make  a  wide‐ranging  comparative  analysis  of  huntingtin homologues  in  both  deuterostome  and  protostome  branches  (includes  17  sequences  from 11 vertebrates, 2 tunicates, and 4 insects) to compare the primary sequence of the protein  homologues  through  multiple  alignment.  The  alignment  of  huntingtin  from vertebrates  reveals  a  high  percentage  of  homology  in  the  primary  sequence.  This similarity  excludes  the  possibility  to  obtain  some  informations  about  the  evolution of the protein and the presence of potential functional domains.  To  reconstruct  the  evolution  of  the  sequence  of  huntingtin  we  choose  to  cloned huntingtin  homologues  from  more  ancient  species.  To  add  an  important  point  in evolution,  we  cloned  the  most  ancient  deuterostome  homologue  (i.e.,  sea  urchin 
Strongylocentrotus  purpuratus  huntingtin),  which  is  present  at  the  base  of  the deuterostome–protostome divergence and is one of the oldest still  living deuterostome organism.  Sea  urchin  is  a  not  chordate  and  it  is  characterized  by  a  relative  poor organized nervous system. These features led us to analyze a huntingtin homologue in a specie  more  divergent  from mammalians.  Along  the  deuterostome  branch  we  cloned also  huntingtin  from  Branchyostoma  floridae  and  Ciona  intestinalis,  chordate  but  not vertebrate, more evolved compared to sea urchin. Comparison of the gene structure of the  entire  group  of  homologues  also  showed  that  the  gene  has  evolved  along  the deuterostome  branch  by  allowing  a  progressive  increase  in  the  number  of  exons depending on phylogenetic distance, whereas the evolution of the gene (and protein) in the  protostome  branch  is  more  heterogeneous.  This  suggests  that  the  protostome branch has  less stringent  functional constraints and that  the  function of  the protein  in protostomes  may  be  involved  in  different  biological  functions.  The  study  of  primary aminoacid  sequences of different huntingtin homologues also highlighted a number of other important aspects:  1)  huntingtin  consists  of  3  major  conserved  regions  corresponding  to  blocks  1–386 (htt1), 683–1,586(htt2), and 2,437–3,078 (htt3) of human htt;  2) huntingtin primary sequence  follows a more progressive and  linear evolution along the deuterostome branch and is more heterogeneous in the protostomes; 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3)  the  polyQ  evolution  is  a  characteristic  typical  of  deuterostomes whose  appearance dates back to sea urchin divergence and whose position is conserved, whereas its length increases; (Figure 3A) 4)  the  Ciona  genus  has  lost  the  polyQ while  accumulating more  differences  in  its  N‐terminal fragment;  5) the drosophilids accumulate differences in the N‐terminal portion of the protein due to a large aminoacid insertion without any polyQ;  6) when polyQ length increases along vertebrates and couples with the polyP tract, the conservation of the N‐terminal domain becomes more stringent.  We speculate that the evolution of the primary huntingtin aminoacid sequence parallels the particular evolution of the nervous system. At a biological level:  1)  the  sea  urchin  nervous  system  is  poorly  organized  in  comparison  with  that  of vertebrates;  2) although belonging to the chordates, Ciona has a totally differently organized nervous system from that of vertebrates;  3) vertebrates all share the same structural organization of the nervous system, whose complexity  increases  progressively  with  the  development  of  the  most  anterior  brain structures (telencephalon);  4)  the  structuring of  the nervous  system along  the protostome branch has  followed a different type of developmental program (metamerism).  At anatomical level, the evolution of the nervous system along the deuterostome branch has progressively increased its anterodorsal positioning. On these evidences we suggest that, along the deuterostome branch, huntingtin may have become progressively more important for nervous system (Tartari et al. 2008). 
 
1a. The evolution of the polyQ Through  our  bioinformatic  studies  we  observed  a  particular  evolution  of  the characteristic polyQ  tract. This  sequence,  that  is probably envolved  in protein‐protein interaction, is a feature of deuterostomes, since in protostomes huntingtin homologues (i.e.  Drosophila  melanogaster)  there  is  no  presence  of  any  polyQ  tract.  This  repeat appears at  the base of deuterostome branch  in sea urchin specie, as a NHQQ sequence seem  to  be  a  primitive  polyQ.  Along  the  phylogenetic  tree  the  polyQ  expands  and maintained  the  same position.  In Branchyostoma  floridae,  cephalochordate,  huntingtin has QQ tract. In more evolved species as vertebrates the polyQ became composed by 4Q 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in  fish  and  other  vertebrate.  The  poly  Q  increased  in  length  through  the  evolution.  It expands from vertebrates to mammals, as rodents had 7‐8Q and it reached its maximum expansion in humans in which polymorphic stretch is present. In protostomes no polyQ has  been  found  probably  as  a  consequence  of  a  different  evolution  of  huntingtin sequence, and possible relative domains. 
 
1b. Huntingtin has different protein domains The bioinformatic study we performed gave us some interesting informations about the presence  of  different  protein  domains.    The  multialignment  of  different  huntingtin homologues allow us to reconstruct three main region of huntingtin protein. Huntingtin seems  to  have  three  main  block,  corresponding  to  position  1–386  (htt1),  683–1,586(htt2), and 2,437–3,078 (htt3) of human htt. The C‐terminal portion of the protein is  well  conserved  during  evolution,  while  the  N‐terminal  tract  exhibits  more  recent evolution  of  the  sequence  (Figure  3B).  For  this  reasons we  speculate  that  huntingtin critical domain resides in the N‐terminal portion of the protein, in which the polyQ first arose  450  MYA  and  has  been  specifically  maintained  (except  in  Ciona)  in  the  same position  although  gradually  expanding.  A  particular  function  of  huntingtin  could  be evolved  in parallel during phylogenesis  in more evolved  species. As the appearance of the  polyQ  is  shown  only  in  deuterostomes  it  is  also  possible  that,  further  in  the evolution, huntingtin acquired in this branch a glutamine‐dependent function, which is particularly important for neurons.  
2.  Producing  expression  vectors  bearing  N­terminal  portion  of  huntingtin  from 
different species To  reconstruct  the  huntingtin  evolution  and  to  understand  better  its  function  during phylogenesis,  we  decided  to  test  the  activity  of  several  huntingtin  homologues.  We expressed  these  molecule  in  a  cell  system  depleted  of  endogenous  huntingtin,  i.e. Embryonic Stem cells lacking huntingtin. Firstly we looked at the phenotype occured in absence  of  huntingtin  in  ES  cells  in  self‐renewal  condition  and  applying  neural differentiation protocol. In parallel we cloned different huntingtin homologues from key species  in phylogenetic  tree. Then we checked  the activity of  these homologues  in  the ability to rescue huntingtin depletion phenotypes. Through multialignment analysis we  firstly designed and produced several  expression vectors  containing  the  N‐terminal  portion  of  different  huntingtin  homologues, 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approximately  the  first  500  aa  of  the  primary  sequence.  The  homologues we  choosed are  from  deuterostomes: Homo  sapiens, Mus  musculus,  Branchyostoma  floridae,  Ciona 
intestinalis,  Strongylocentrotus  purpuratus.  We  choose  also  a  protostome  homologue 
Drosophila  melanogaster  and  Dyctiostelium  discoideum  as  the  first  multicellular organism in which huntingtin protein  is  found (Figure 4). We cloned the  fragments by PCR  amplification,  using  primers  containing  tag‐HA  sequence  to  detect  different huntingtin  fragments.  Strongylocentrotus  purpuratus,  Ciona  intestinalis,  Branchiostoma 
floridae,  Mus  musculus  and Homo  sapiens  huntingtin  was  produced  by  specific  cDNA amplification.  The  constructs  containing  Dyctiostelium  discoideum  and  Drosophila 
melanogaster  huntingtin  were  produced  by  a  collaboration  of  Prof.  Gusella (Massachusetts  General  Hospital  Cambridge,  MA).  After  amplification  by  PCR  each fragment  was  transfered  in  a  pCAG  expression  vector.  We  test  the  expression  of constructs  by  transfection  in mammalian  cells.  After  transfection  the  presence  of  the huntingtin fragment was evaluated by immunocytochemistry 48hs post‐transfection. 
 
3. Developing a cellular tool to study huntingtin function To study  the  involvement of huntingtin during  the early phase of neural development we set up an in vitro paradigm of embryonic development. We choose Embryonic Stem cells (ES) and their ability to differentiate in a wide range of cell types. To study the role of huntingtin during embryogenesis we use an huntingtin depleted ES cell line, in which two  alleles  of  the Hdh gene  have  been  inactivated  (Hdhex4/5)  (Duyao  et  al.,  1995),  and their wild‐type counterparts. ES Hdhex4/5  line was produced exciding the exons 4 and 5 of huntingtin gene. As a consequence of this deletion, in these cells huntingtin a shorter mRNA was produced but no protein is translated.  
3a. Huntingtin depleted cells are more vulnerable to serum deprivation under self­
renewal conditions First  of  all  we  characterized  ES  lacking  huntingtin  (ES  Hdhex4/5)  under  self‐renewal conditions.  Cells  were  assayed  by  immunoreactivity  to  typical  embryonic  stem  cells markers  as  the  transcription  factor  Oct4.  Wild‐type  and  Hdhex4/5  ES  cells  are  both positive for Oct4 and shown the same morphology (Figure 5). Then we check whether the absence of huntingtin can alter the typical ES cells features. We  choose  two  different  assay  to  test  cell  viability:  MTT  assay  and  Caspase‐3  active assay. 
Results 
25 
Firstly MTT reduction to formazan was used. The growth rate of huntingtin depleted ES was  compared  to  the  one  of  wild‐type  cells  over  time  under  basal  proliferation conditions. The resulting growth curve of undifferentiated ES cells expressing both (ES 
Hdh+/+), and none (ES Hdhex4/5) huntingtin alleles reveals that the absence of huntingtin does not  impair  the growth  rate within  the  first 48 hours of  culture. Only after 48‐96 hours,  in  proliferation  medium,  huntingtin‐depleted  ES  cells  start  to  show  a  lower capacity to reduce MTT, meaning that less viable ES Hdhex4/5 cells were present at those time points, when compared  to both ES Hdh+/+  cell  line. The  same assay was  repeated with  cells  kept  in  proliferation media  but  deprived  of  serum  for  up  to  96  hours.  It  is important to note that under this condition of serum deprivation, none of the cell lines undergo differentiation.  Under  this  stress‐induced  condition,  the  growth  curve  of  two cell  lines  was  affected,  and  the  number  of  viable  huntingtin  depleted  cells  was significantly lower than that of wild‐ type cells (Figure 6A). Then we check huntingtin knock out cells in a well establish huntingtin activity, such as active  Caspase‐3  assay.  Wild‐type  cells  and  Hdhex4/5  are  plated  in  normal  growth condition. After 24hs, complete medium was replaced with serum deprived medium and the active Caspese‐3 is measured after 24 hours of serum deprivation. ES Hdhex4/5 cells show a greater increase of caspase‐3 activity, when compared to wild‐type cells. These findings  clearly  indicate  that  huntingtin‐depleted  mouse  embryonic  stem  cells  (ES 
Hdhex4/5) are particularly vulnerable to serum deprivation (Figure 6B). 
 
3b. “Rosetteless phenotype” in absence of huntingtin during neural differentiation To study huntingtin role during neural development we have subjected ES cells Hdhex4/5 and  their  wild‐type  counterparts  to  a  neural  differentiation  protocol  in  monolayer culture,  according  to  Ying  et  al.,  2003  (Figure  7).  This  protocol  provides  a  simple, rational  system  for  conversion  of  ES  cells  into  neural  precursors  and  thence  into neurons and glia, which likely results from a better mimicry of the events that occur in the embryo. Particularly, during the first stage of neural development (day 6‐8) ES wild‐type  cells  are  converted  into  neural  precursors  forming  neural  tube‐like  rosettes, radially organized columnar epithelial cells. As neural rosettes continue to grow in vitro, they mimic the processes occurring during neurulation and neural tube growth. Rosette cells gradually give rise to differentiated cells such as neurons migrating radially away from the  rosettes  structure. Neural rosettes are positive  for neuroectodermal markers such as Nestin, a protein of intermediate filament, N‐cadherin, typical protein of neural 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adherent junctions, ZO‐1 typical protein of the tight junction. Nestin staining shows the presence of neural precursors radially arranged, along all rosettes structure. N‐cadherin and ZO‐1 staining have a particular  luminal  localization,  indicating a strict apical‐basal polarity. As neuroephitelium in vivo neuroephitelial cells inside rosettes are anchored to one  another  apically  through  junctional  complex  characterize  by  more  apical  tight junction expressing ZO‐1 followed by N‐cadherin expression in adherent junction. Under differentiation  condition  we  find  that  in  absence  of  huntingtin  aberrant  spatial organization of neural precursors has been observed at day (6‐8) as judged by Nestin, N‐cadherin and ZO‐1 expression, which we named "rosetteless phenotype" (Figure 8). We show  a  severe  reduction  in  neural  rosettes  number  and  size  in  spite  of  a  comparable number  of  Nestin  positive  cells.  We  show  N‐cadherin  and  ZO‐1  missing  the  typical luminal staining suggesting a particular disorganization of neural precursors. Then we tested this phenotype also in an other cell line lacking huntigntin. The model we chose, null huntingtin ES (Hdhpr/ex1),  is characterized by the deletion of  the promoter and the exon 1 of huntingtin gene. In these cells no mRNA production is detected (Zeitlin et al., 1995). We test  this cell  line to  the ability  to  form rosettes under neural differentiation protocol. Our  data  demonstrate  that  “rosetteless  phenotype”  is  evident  also  in  this  cell line, confirming that this phenotype is due to the absence of huntingtin, and it is cell‐line independent  (Figure  8).  We  quantified  this  disorganization  by  using  the  imaging software ImageJ. We performed an immunocytochemistry for Nestin neural marker. 12 different  fields  were  acquired  at  fluorescence  microscope.  We  calculated  the  total surface occupied by Nestin positive cells in each field. After that, we design a mask  for each rosette in the field, then we measure the surface occupied by Nestin positive cells IN  and  OUT  of  the  rosettes  (Figure  9A).    Quantification  by  this  imaging  technique showed an approximately 70% reduction of Nestin positive cells inside rosettes in both the two different batches of cell lines depleted by endogenous huntingtin (Figure 9B).  
3c. Validation of “Rosetteless phenotype”  RNA interference approach has been used to analyse the role of endogenously expressed huntingtin  on  rosettes  formation.  Huntingtin  siRNA  was  delivered  at  day  0  of  the monolayer protocol and decreased huntingtin up to 40% of  the scrambled‐transfected level after 24 hours. The reduction is maintained until day 5, a time point at which the fate of neural precursor cells has been already defined (Figure 10A). At day 8 huntingtin 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knockdown  in  Hdh+/+  causes  defects  of  neural  precursors  spatial  organization,  with respect to cells treated with scramble RNAi (Figure 10B).  On  the  contrary,  expression  of  full‐length  mouse  huntingtin  in  a  null  huntingtin background led to a nearly complete rescue of the “rosetteless phenotype”. We described the presence of neural rosettes as in Hdh+/+ cells, as an approximately 65% increased of Nestin positive cells inside rosettes was found (Figure 10C‐D). We  also  established  co‐culture  systems  to  understand whether  the  presence  of wild‐type cells can induce Hdhex4/5 to produce neural rosettes.   Wild‐type cells (Hdh+/+) have been equally mixed with cells lacking huntingtin stably expressing eGFP (Hdhex4/5 eGFP) and  wild‐type  cells  stably  expressing  eGFP  (Hdh+/+eGFP)  have  been  mixed  with  cells lacking huntingtin (Hdhex4/5). Cells were subjected at neural monolayer differentiation as above. Cells have been fixed at day 8 and immunodecorated for Nestin, N‐cadherin and eGFP. We  observed  the  formation  of  neural  rosettes  composed  exclusively  by Hdh+/+ cells,  whereas  Hdhex4/5  cells  still  remained  unable  to  form  rosettes  in  both  the experimental  conditions  (Figure  11).  Therefore  the  ability  to  form  rosettes  is  a  cell‐autonomous process. Together these results show that wild‐type ES cells does not exert a  positive  effect  on  cells  that  are  null  for  huntingtin  gene,  and  no  secreting  factors support huntingtin depletion defect. Altogether these data indicate that huntingtin is involved in the process underlying the formation of neural rosettes, suggesting a possible role of the protein in regulating early phases of neural development.    
3d.  Neural  precursors  defects  leads  to  vulnerable  mature  neurons  in  absence  of 
huntingtin During  the  first  stage  of  neural  differentiation we  shown  that  cells  lacking  huntingtin exhibit a defect in spatial organization in spite of immunoreactivity to neuroectodermal markers. We also  testing  the ability of huntingtin knock out  cells  to undergo  terminal differentiation  to  product  mature  neurons  and  glial  cells.  We  performed  some experiments of monolayer differentiation until 21 days of differentiation. During the late stage  of  maturation,  we  check  the  presence  of  mature  neurons,  MAP2  (Microtubule Associated Protein) and astrocytes GFAP (Glial Fibrillary Associated Protein) reactive. At D14  of  differentiation  we  found  the  same  rate  of  mature  neurons  and  glia  cells, indicating  that  “rosetteless  phenotype” didn’t  impair  the abilty of huntingtin knock out cells  to  differentiate  in  mature  neural  cells  (Figure  12).  Some  of  mature  neurons 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observed are GABA (Gamma Amino Butyric Acid) positive, demonstrating the ability of cells  lacking  huntingtin  to  differentiate  in  GABAergic  neurons,  as  allowing  by  Ying protocol.  In spite of an equal rate of differentiation, we also observe a decrease  in  the number of mature neurons at D21 of neural differentiation protocol, suggesting that the absence of huntingtin causes the production of more vulnerable neurons. Therefore we check the immunoreactivity for GAP‐43 (Growth Associated Protein) at D21. GAP‐43 is a protein expressed at high levels in neuronal growth cones during development. We can observed a reduction of GAP43 positive cells, suggesting mature neurons from Hdhex4/5 cells  are defective  in protrusions growth and   and have  less viability  in  vitro  until  the end of differentiation (Figure 12).  
 
4.  Huntingtin  drives  rosettes  formation  through  N­cadherin­mediated  cell 
adhesion To understand  better  the mechanism  causing  “rosetteless  phenotype”,  firstly, we  assay the migration ability of huntingtin knock out cells, to test if defects in  migration events could  led  to  impairment  in  rosettes  formation.  By  computerized  video  time‐lapse microscopy we  found  that  wild‐type  cells  and  huntingtin‐depleted  cells  show  similar migration  speed  (Hdh+/+:0,42um/min±0,27  and  Hdhex4/5:0,33  um/min±0,22),  then  we excluded  the  possibility  that  defects  in  cell  migration  may  be  responsible  for  the 
“rosetteless phenotype” (Figure 13).  Then we want to check if the aberrant spatial organization of neural precursors cells in rosettes may be due to defects in cell anchoring. We focussed on adhesion molecules as potential intermediates of huntingtin function at the stage of rosettes formation. Among the  several  candidates,  N‐cadherin,  is  typical  located  into  adherent  junction  and  it  is critically  involved  in  the  regulation  of  cell  adhesion  and  cell  migration  in  the  CNS (Halbleib  and Nelson, 2006). N‐cadherin  is a  cell  surface glycoprotein mediating Ca2+‐dependent  homophilic  cell  adhesion  and  it  is  mainly  expressed  in  neuronal  cells, physically  associated with  NMDA  receptor  (Husi  et  al  2000).  It  is  involved  in  neurite outgrowth,  neuron  pathfinding  and  in  synaptic  structure  it  ensures  cell‐cell comunication. Moreover N‐cadherin has a role in the maintenance of epithelial integrity, heart tube formation, neurulation and somitogenesis (Radice et al 1997). Several studies demonstrate  that N‐cadherin  has  a  foundamental  role  in  neurulation. N‐cadherin  null embryos  die  at  E9.5,  because  of  a  cell  adhesion  defect  in  the  developing myocardium  (Radice et  al 1997),  and neurulation defects also occur,  the neural  tube  is  still  formed 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but has an abnomal apparence (Radice et al 1997). N‐cadherin morpholino in Zebrafish causes blockage of neural  tube  formation. The cells are not defective  in  their ability  to form  protrusions,  but  they  are  unable  to  mantain  them  stably  (Hong  and  Brewster 2006).  For  these  reasons  we  choose  N‐cadherin  as  candidate  to  investigate  whether  N‐cadherin‐pathway  could  be  affected  in  the  absence  of  huntingtin,  contributing  to  the “rosetteless phenotype”.  
4a. Loss of wild type huntingtin does not affect N­cadherin expression level First  of  all  we  check  the  expression  level  of N‐cadherin  during  neural  differentiation, assaying mRNA and protein  levels. N‐cadherin mRNA  levels  are assayed  in Hdh+/+  and 
Hdhex4/5  from D0  to D7 of differentiation protocol by Real‐time PCR. No changes  in N‐cadherin mRNA  levels were observed  in  the absence of huntingtin,  at  the  same stages (Figure 14A). We performed also western blotting analyses to detect N‐Cadherin protein level on Hdh+/+ and Hdhex4/5 cells during the initial stage of the monolayer protocol (day 0, 5, 6, 7 and 8). No differences in full‐length N‐cadherin levels have been found in Hdh+/+ and Hdhex4/5  starting  from day 5. These preliminary analysis demonstrate that  there  is no  change  in  the  total  amount  of N‐cadherin  in Hdhex4/5  cells with  respect  the  control cells.  




observed.  Similar  results have  been obtained  in Hdhpr­ex1  compared  to Hdh+/+  at day  8 (Zeitlin et al. 1995) (Figure 14B‐C).  We  want  to  analyse  also  the  CTF‐1  production  using  a  typical  pharmacological treatment with Ionomycin (2.5 µM concentration for 30 min at day 8). This compound is commonly  used  to  promote  cadherin  shedding  through  stimulation  of  calcium  influx (Marambaud  et  al.  2002).    We  performed  treatments  with  Ionomycin    at  D8  of differentiation and after 30 minutes  cells were  lysated.  In  these  condition both Hdh+/+ and Hdhex4/5  lines  is  responsive  to  the  treatment,  but Hdhex4/5    cells  shown  an  higher amount of CTF‐1 fragment (Figure 14D). These data suggest that huntingtin controls the proteolytic processing of N‐cadherin, since in its absence an aberrant cleavage process occurs. Therefore this alteration could regulate the anchoring of neural precursors into the rosettes.  
4c. Huntingtin controls ADAM­10 activity   Multiple line of evidence indicates ADAM10 is the major metalloproteinase responsible for N‐cadherin cleavage in neuronal cells. Therefore, we investigated ADAM10 level and activity  in  control  and  Hdhex4/5  cells.  Western  blot  for  ADAM10  showed  three immunoreactive bands at 100 kDa, 80 kDa and 60 kDa, respectively indicating ADAM10 precursor,  the  partially  processed  form  and  the  catalitically  active  protein. We  found that  levels of precursor and  inactive  form of ADAM10 are similar between control and knock‐out  cells. On  the  contrary,  the amount of  the processed and active 60‐kDa  form shows  a  2‐fold  increase  in  Hdhex4/5  compared  to  Hdh+/+  (Figure  15A‐B).  We  suggest increase N‐cadherin cleavage in the absence of huntingtin is due to increased activity of ADAM10.  Accordingly  the  production  of  CTF1  fragment was  completely  blocked with the ADAM10 inhibitor Tissue Inhibitor of MMPs‐1 (TIMP1) both in wild‐type and knock‐out  cells  (Figure  14D). Altogether  these  data  indicate  that  normal  huntingtin  controls ADAM10‐mediated cleavage of N‐cadherin.  
4d. Validation of huntingtin role in ADAM­10 mediated N­cadherin cleavage To  confirm  the  possible  link  between  ADAM‐10,  N‐cadherin  and  huntingtin, we  have performed  some  experiments  modulating  N‐cadherin  and  ADAM‐10  expression.  We have expressed a mutant form of N‐cadherin (HA tagged) resistant to ADAM‐10 cleavage in Hdhex4/5 cells. Stable Hdhex4/5 cell line overexpressing mutated form of N‐cadherin was produced  and  subjected  to  neural  differentiation.  We  observed  that  the  mutant  N‐
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cadherin  transgene  rescued  the  “rosetteless  phenotype”,  suggesting  that  abnormal cleavage  of  N‐cadherin  is  responsible  for  the  observed  defect  in  rosette  formation (Figure  16A). Moreover  rosettes  produced  in  the  presence  of mutated N‐cadherin  are immunoreactive  for  HA,  demonstrating  that  full‐length  N‐cadherin  is  responsible  of rosettes maintenance. Moreover, the production of CTF1 fragment is blocked in Hdhex4/5 cells (Figure 16B‐C). Similar results have been obtained when ADAM‐10 has been knock‐down  in Hdhex4/5  cells  by  RNAi,  leading  to  a  significant  decrease  in  the  production  of CTF1  (Figure  17A‐B).    These  data  confirm  that  huntingtin  controls  the  formation  of neural rosette by modulating ADAM‐10‐mediated N‐cadherin cleavage.   
5. Assaying the activity of huntingtin N­terminal domain by rescue experiments in 
huntingtin depleted cells Our  recent  bioinformatics  studies  and  cross‐evolution  comparison  of  huntingtin homologues  suggest  that huntingtin  function(s) may be  embedded  into  three possible protein domains, one of which, the N‐terminal fragment, containing the polyQ and more recently evolved, may be responsible  for the neuronal functions of the protein (Tartari et al. 2008). We have chosen to perform rescue experiments in huntingtin‐null ES cells to  evaluating  the  activity  of  the  N‐terminal  huntingtin  fragment  and  to  test  the hypothesis  of  a  progression  in  neuronal  function  of  the  N‐terminal  portion  during evolution.  We  selected  a  range  of  N‐terminal  fragments  of  huntingtin  from  ancient species  and organisms of  the deuterostome branch ‐ with progressively more evolved nervous systems, one specie in the protostome branch and a more ancient specie before the  divergence  of  protostome‐deuterostome.  The  huntingtin  homologues we  used  are from: Dictyostelium discoideum  (Dd), Strongylocentrotus purpuratus (Sp), Mus musculus (Mm), Homo sapiens (Hs) with 15Q or mutated form with 128Q, Drosophila melanogaster (Dm) (Figure 18).  
5a.  Production  and  characterization  of  stable  cell  lines  of  Hdhex4/5  expressing  N­
terminal fragment from different species ES  Hdhex4/5  are  transfected  with  pCAG  expression  vectors  bearing  the  N‐terminal fragment  of  huntingtin  from  different  homologues.  We  have  cloned  N‐terminal huntingtin  cDNA  from Dyctiostelium  discoideum,  a  motile  soil  amoeba  at  the  point  of transition  from  unicellular  to multicellular  organisms with  no  nervous  system,  at  the base of the Metazoan phylogenetic tree. We have also cloned the N‐terminal huntingtin 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from  Strongylocentrotus  purpuratus  (sea  urchin)  the  oldest  deuterostome  still  living with  a  primitive  nervous  system  organized  into  radial  nerves.  Then,  N‐terminal huntingtin from organisms with a nervous system of increased complexity such as Mus 







- ES Hdhex4/5 C‐Mm To  test  the  expression  of  the  transgene,  we  assayed  cell  lines  by  western  blot  and immunocytochemical  analysis.  All  stable  cell  lines  expressed  the  transgene  as  shown using huntingtin antibody or HA antibody (Figure 19A‐B).  
5b.  Rescue  assay  during  neural  differentiation:  the  ability  to  form  rosettes  is  a 
huntingtin function included in its N­terminal domain First,  we  expressed  the  first  550  aa  of Mus musculus  huntingtin  in Hdhex4/5  that  have been subjectd to neuronal differentiation towards the monolayer protocol. A full‐rescue of  the  “rosetteless phenotype” has been observed  similarly  to what observed after  full‐length wild‐type  huntingtin  transfection.  Importantly,  no  rescue  in  rosettes  formation has  been  detected  when  C‐terminal  portion  of  huntingtin  was  transfected  in Hdhex4/5 (Figure 20). Rescue of  the “rosetteless phenotype”  is  independent  from transgene  level, since  low  or  high  amount  expression  of  N‐terminal  mouse  huntingtin  both  led  to rosettes  formation  in Hdhex4/5.  These  data  demonstrate  that  the N‐terminal portion of 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huntingtin  is  a  protein  domain  that  controls  the  process  of  rosettes  formation  during early neural development.   
5c. The rosetteless phenotype is rescued by N­terminal domain from species with a 
more evolved nervous system Then, we tested the possibility that the ability to regulate rosettes formation carried by the  N‐terminal  domain  is  a  property  of  huntingtin  that  has  emerged  during deuterostome  evolution. All  transgenic  cell  lines  expressing  the N‐terminal  portion  of huntingtin  were  tested  during  neural  differentiation  and  their  ability  to  complement defects at the level of rosettes formation and N‐cadherin cleavage, previously observed in  Hdhex4/5  cells,  has  been  evaluated.  The  cells  have  been  subjected  to  neuronal differentiation  in monoculture  and  immunodecorated  at  day  8  for Nestin, N‐Cadherin and ZO‐1. We quantified the “rosetteless phenotype” with imaging analysis we set up for this  protocol.  Our  experiments  indicate  that  overexpression  of  N‐terminal  huntingtin from Dictyostelium  discoideum  shows  null  ability  to  restore  “rosetteless  phenotype”  in 
Hdhex4/5  cells.    An  approximately  5%  rescue  capability  was  found  when 
Strongylocentrotus  purpuratus  N‐terminal  huntingtin  has  been  expressed.  On  the contrary, N‐terminal portions from species with a progressively more evolved nervous system (Mus musculus and Homo sapiens) show full rescue of the “rosetteless phenotype”. Moreover,  rosettes  formation  is  strongly  impaired  and  similar  to  what  observed  in 
Hdhex4/5  cells  when  N‐terminal  from  Drosophila  melanogaster  was  expressed,  thus suggesting  that  huntingtin  has  not  evolved  cell‐adhesion  functions  in  the  protostome branch (Figure 21A‐B).  Accordingly,  N‐cadherin  cleavage  (determined  by  measuring  CTF‐1  production)  still remains high  in Hdhex4/5  cells  expressing  the N‐terminal huntingtin  from Dyctiostelium 
dyscoideum  and  Strongylocentrotus  purpuratus.  On  the  contrary,  CTF‐1  level  is significantly decreased when huntingtin from more evolved organisms is expressed (i.e. 
Mus  musculus  and Homo  sapiens)  (Figure  22A‐B).  As  a  consequence  of  the  rescue  in “rosetteless  phenotype”  we  observed  a  restoring  of  GAP43  staining  at  D21  of differentiation  in  cells  expressing  human  and mouse  N‐terminal  portion,  in  spite  of  a null  rescue  in  transgenic  line  overexpressing  C‐terminal  portion  of huntingtin  (Figure 22C). 
Results 
34 
5d. The impact of the polyQ tract in “rosetteless phenotype” Therefore  we  asked  whether  an  expanded  polyQ  could  affect  the  process  of  rosette formation  and  cell  adhesion  function.  We  overexpressed  N‐terminal  human  mutant huntingtin  with  128Q  in Hdhex4/5  cells  and  found  that  the  “rosetteless  phenotype”  and abnormal  N‐cadherin  cleavage  were  partially  rescued  after  N‐terminal  mutant huntingtin expression (approximately 20%) (Figure 23A‐B‐C). Moreover, after 21 days of neuronal differentiation the number of MAP2 positive cells is not reduced, and GAP43 staining  showed  no  particularly  differences  in  the  mutant  huntingtin  expressed  cells (Figure  23D).  These  data  suggest  that  more  slight  impairments  could  occur  in  the presence of mutation, as a consequence of an aberrant neural precursors organization, in spite of a correct differentiation of neurons. Altogether these results suggest that the polyQ in the pathological range alters huntingtin functions during development, possibly causing  subtle  molecular  and  cellular  abnormalities  that  compromise  aspects  of  the specification and maturation of neurons and subsequently make them more  vulnerable to late life stressors.  
5e.  The  anti­apoptotic  activity  of  huntingtin  is  an  old  born  function  conserved 






Huntingtin is a large, ubiquitous, partially unknown protein, in which mutation in its N‐terminus  is  the cause of genetic, neurodegenerative disease called Huntington Disease. From the discovery  in 1993 of  the disease  causing gene encoded  for huntingtin, some research groups had focus their attention to the molecular mechanism of HD to reveal the  basis  of  the  pathology.  Several  studies  during  the  years  had  demonstrated  that mutation occurred  in huntingtin gene  cause  the production of  a mutated protein,  that exert  its  toxic  activity,  lead  to  neuronal  death.  Although  the  presence  of  mutated huntingtin, from one decade it is known that the loss of wild‐type protein can contribute to pathogenesis of HD  (Cattaneo et  al 2000). This hypothesis had a new  impact  in HD research since many scientific groups focused their efforts in study phenotypes caused by  loss of normal huntingtin. This studies revealed that huntingtin  is embryonic  lethal during embryogenesis  and  it  exerts a  fundamental  role  in  the adult brain as a protein sustaining viability and health of mature neurons. Huntingtin is shown to be involved in neuron  viability  and  maintenance,  but  its  really  and  univocal  function  is  already unknown.  Huntingtin  is  a  protein  sui  generis,  with  no  particular  sequence  homology with  other  known  protein.  Some  studies  turn  to  understand  its  structure  not  reveal definitive informations about its possible structure and domains.  This  study,  object  of  my  PhD  project  is  focused  on  understand  normal  huntingtin function. First of all, we performed a bioinformatic study in which multialignment of 17 different  homologues  of  huntingtin,  both  in  deuterostome  and  protostome  branches (includes 17 sequences    from 11 vertebrates, 2  tunicates, and 4  insects) were analyze. Through this analysis we dissect the primary aminoacid sequence of huntingtin to reveal the presence of possible protein domains.  
Studying huntingtin protein structure In  the  first  part  of my  project we  performed  a  bioinformatic  analysis  of  the  primary aminoacid  sequence  of  several  huntingtin  homologues  in  order  to  reconstruct  the evolution of huntigntin protein along the evolution. We choose some known homologues of  huntingtin  from  deuterostomes  and  protostomes  (i.e. Mus musculus,  Homo  sapiens, 
Drosophila melanogaster) and we cloned also huntingtin  from new ancient species (i.e. 
Strongylocentrotus  purpuratus,  Ciona  intestinalis,  Branchiostoma  floridae).  Our comparison  of  huntingtin  homologues  in  multialignment  analysis  first  revealed  that huntingtin  has  three  major  domains.  During  phylogenesis  C‐terminal  domain  is maintained  conserved  in  metazoan,  while  N‐terminal  portion  presents  a  more  re‐arranged  sequence  showing  more  recent  evolution.  In  deuterostomes  N‐terminal 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domain  has  a  linear  evolution  from  the  echinoderms  to  mammals,  with  a  particular expansion  of  the  polyQ  tract,  while  protostomes  diverged with  a  different  aminoacid sequence  and  the  characteristic  lost  of  polyQ. The  aminoacid  primary  sequence  trend suggest  us  that  huntingtin  could  maintain  a  conserved  function  associated  to  its  C‐terminal  domain  during  phylogenesis  while  N‐terminal  portion  specified  a  different function in protostomes and deuterostomes. Moreover, look at the particular evolution and  specification  of  the  nervous  system  structures,  and  complexity  along deuterostomes,  we  speculate  that  the  evolution  of  the  primary  huntingtin  aminoacid sequence  parallels  the  particular  evolution  of  the  nervous  system.  We  therefore speculated that the N‐terminal portion of huntingtin could be endowed with functional activities  that  become  progressively  more  specialized  during  deuterostome  evolution and critical for adult neurons (Tartari et al. 2008).  
Huntingtin function during neural development To analyse the role of normal huntingtin since its early embryonic function we choose to study what is the role of the protein during the early phase of embryo development, in particular during the early phases of neural development. To dissect how this function is acquired during phylogenesis we choose to study neural differentiation process and the activity of the N‐terminal domain during neurulation.  We selected Embryonic Stem cells and their ability to differentiate in all cell type of the body, as a tool to study early embryonic development. We performed some experiments to understand the role of huntingtin during the  first stages of neural commitment and the followed neuronal differentiation. Using  huntingtin  deficient  embryonic  stem  (ES)  cells  and  an  in  vitro  neural differentiation  protocol  that  allow  the  multistep  processes  occurring  during  neural development, we have found that huntingtin regulates biology of neural rosettes. Neural rosettes  are  an  early  transient  neural  structure  composed  of  radially  organized columnar epithelial cells resembling in vitro the processes occurring during neurulation. The differentiation potential of neural rosettes  corresponds  to  that of  the neural‐plate stage  cells,  suggesting  they  can mimic  in  vitro  the  neural  tube  growth. We  found  that huntingtin  loss  causes  a  defect  in  spatial  organization  of  the  developing  neural progenitors, which results in decrease of rosettes number and size, which we called “the 
rosetteless phenotype”. In the absence of huntingtin we observed a normal commitment of ES  cells  into neural precursors,  as demonstrates by the  immunoreactivity  to  typical neural  precursors  markers  Nestin  and  N‐cadherin,  however  the  neural  precursors 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produced  is  unable  to  formed neural  rosettes.  These  data  suggest  that,  by  controlling rosettes formation, huntingtin may participate at the cytoarchitecture of the developing CNS.  We  test  this  activity  of  huntingtin  modulating  its  expression  by  several experimental approaches.  i) We  check  the  rosetteless  phenotype  in  two  different  batches  of  huntingtin depleted  cells  (Hdh4/5  and  Hdhpr­ex1),  to  be  sure  that  the  phenotype  we observed is cell line independent. With this experiments we demonstrate that 
rosetteless phenotype is indipendent by the variability of different cell lines.  ii) Then we  knock  down  endogenous  huntingtin  in wild‐type  cells  demonstrating that  rosetteless  phenotype  occurs  downregulating  the  expression  of huntingtin.  iii) Cell  depleted  of  endogenous  huntingtin  are  able  to  restore  rosettes  formation activity through a stably over‐expression of full‐length huntingtin protein.  iv) To  test  whether  the  presence  of  wild‐type  cells  can  rescue  the  defect  in huntingtin depleted cells, we peformed some co‐colture experiments to test if released  factors  by  wild‐type  cells  can  contribute  to  restoring  huntingtin depletion  effects.  Our  data  demonstrated  that  no  exogenous  factors  can rescue rosetteless phenotype in huntingtin null neural progenitor cells. All  these  experiments  demonstrate  that  huntingtin  has  a  key  role  in  the  formation  of neural  tube‐like  rosettes,  since  its  absence  lead  to  a  severe  disorganization  of  neural precursors  cells.  As  a  consequence  of  the  rosetteless  phenotype  we  observed  that huntingtin  knock  out  cells  are  able  to  differentiate  in  mature  neurons  and  glia,  as described in literature, but neurons formed are more vulnerable. 
Huntingtin regulates cell adhesion N­cadherin mediated In the second part of the project we try to understand better the underlying mechanism that occurs to cause rosetteless phenotype. We shown that huntingtin modulates rosettes formation by regulating cell‐cell interaction mechanisms. We propose a novel partner of huntingtin  that  is  crucial  for  cell  adhesion  at  adherent  junctions,  N‐cadherin.  Several studies  indicate N‐cadherin undergoes ADAM‐10 mediated cleavage  in  its extracellular domain yielding fragments of major importance for the regulation of cell adhesion, cell migration  and  neurites  outgrowth  (Reiss  et  al.,  2005; Halbleib  and Nelson,  2006). We performed some experiment to reveal the role of huntingtin in cell‐adhesion mechanism. Although the same  level of mRNA and total  full  length N‐cadherin protein  in wild‐type and  knock  out  huntingtin  cells,  we  observed  increased  N‐cadherin  cleavage  in  the 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absence of huntingtin during neural development. Higher level of CTF‐1 has been found in  neural  precursors  cells  depleted  of  huntingtin,  which  is  responsible  for  defects  in neural cells spatial organization. We found that higher activity of ADAM10 is responsible for  the  increased  N‐cadherin  shedding  observed  in  the  absence  of  huntingtin.    Some genetic modulation experiments demonstrated  that huntingtin acts  in  concert with N‐cadherin and ADAM‐10 in rosettes formation.  
i) Silencing ADAM‐10 in huntingtin null ES cells can rescue rosetteless phenotype ii) Overexpression of mutant form of N‐cadherin in ADAM‐10 cleavage site is able to restore rosette formation ability in huntingtin null ES cells. Therefore, we concluded that, by controlling ADAM‐10 activity, huntingtin regulates N‐cadherin mediated cell‐cell adhesion mechanisms during neurulation, leads to a correct formation of neural‐tube like rosettes. 
Huntingtin cell adhesion function emerges in deuterostome evolution Finally we want to detect whether N‐terminal portion of huntingtin is responsible of this neural  huntingtin  function  (i.e.  neural  rosettes  formation),  and  how  this  function  is evolved during phylogenesis. We observed that huntingtin N‐terminal domain, but not C‐terminal  one  is  able  to  rescue  rosetteless  phenotype,  when  overexpressing  in huntingtin knock out cells, demonstrating that N‐terminal domain is a functional domain of  the  protein  responsible  of  a  neural  developmental  function  of  huntingtin.  Previous bioinformatics  data  showed  that  the  N‐terminal  fragment  is  the  most  recent  evolved portion  of  huntingtin  during  deuterostome  evolution.  In  this  study  we  provide  a reconstruction of  the  functional activity of  the N‐terminal domain of huntingtin during evolution. We provide evidence that the N‐terminal huntingtin from lower species with no‐nervous system, such as Dyctiostelium discoideum or with a poor organized nervous system as Strongylocentrotus purpuratus is not endowed with neuronal properties (i.e. the  ability  to  regulate  the  neural  precursor  spatial  organization).  On  the  contrary, expression  of  N‐terminal  huntingtin  from  Mus  musculus  and  Homo  sapiens,  show complete  rescue  of  the  “rosetteless  phenotype”.  Our  data  show  also  that  the  expanded polyQ  partially  affects  the  neuronal  activities  associated with  the  N‐terminal  domain, since rosetteless phenotype is partially restored after transfection of mutated form of N‐terminal  human  huntingtin  (with  128Q).  We  also  demonstrate  that  N‐terminal  from 
Dyctostelium discoideum, Strongilocentrotus purpuratus, Mus musculus and Homo sapiens rescue apoptotic  cell death  in a null huntingtin background,  indicating  that huntingtin ability  to  regulate  apoptosis  is  an  ancient  acquisition  of  the  protein  that  has  been 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maintained during evolution. We suggest that huntingtin was born to serve primordial non‐neuronal functions and it is only at later stages that it acquired additional neuronal functions,  in  coincidence  with  the  formation  of  the  nervous  system.  These  neuron‐specific functions have been progressively imposed to the N‐terminal domain in higher species, coinciding with the acquisition of an increasingly more complex CNS.  






We  used  mouse  Embryonic  Stem  cell  lines  either  wild‐type  and  homozygous  for  a knockout mutation in the gene encoding for huntingtin protein. R1 (Hdh+/+), R1‐Hdh4/5‐1d1(Hdh4/5)  (Duayo et  al., 1995), and 129/Sv (Hdh+/+*), 129/SvHdh‐/‐ (Hdhpr­ex1) were used (Zeitlin et al., 1995).  ES  cells were maintained  in  Glasgow Minimal  Essenzial Medium    supplemented with 10%  heat‐inactivated  Fetal  Bovine  Serum  (FBS‐EuroClone,  Italy),    1mM  β‐mercaptoethanol  (GIBCO),  100 µM non  essential  amino  acids  (GIBCO),  1 mM  sodium piruvate  (GIBCO),  2  mM  L‐glutamine  (EuroClone),  100  u/ml  penicillin,  100  µg/ml streptomiycin  (EuroClone)  and  1000  U/ml  murine  Leukemia  Inhibitor  Factor  (LIF‐ESGRO)  (Chemicon)  on  gelatinised  tissue  culture  flasks.  Cells  were  passaged  every  2 days using 0.05% trypsin‐EDTA.  
 
Mouse ES cell monolayer neural differentiation Mouse embryonic stem cell lines used for monolayer neural differentiation (Ying, 2003) experiments.  Before  initiating  differentiation,  ES  cells  were  plated  at  high  density (2x106  cells/  T25  flask)  and  cultured  for  24  hours  in  standard  ES  cell  medium containing  LIF  (as  described  above).  Undifferentiated  ES  cells were  dissociated  using 0.025% trypsin (Gibco, Invitrogen) solution at 37oC, and then plated onto 0.1% gelatin‐ coated tissue culture plastic at a density of 1.0x104/ cm2 in N2B27 serum‐free medium. N2B27  consists  of  a  1:1  ratio  of  DMEM/F12  (Gibco)  and  Neurobasal  (Gibco)  media supplemented  with  0.5%  N2  (Gibco),  1%  B27  (Gibco)  and  0.2%  2‐mercaptothanol (Gibco, Invitrogen). The medium was then changed every other day. From day 9 N2B27 the  cell  colture medium  become  a  1:4 mixture  of  the  same  supplemented media.  For some  experiments,  cells  were  replated  after  7  days  onto  poly‐ornitin  (Sigma)  and laminin  (Gibco,  Invitrogen)  coated  plastic  at  a  density  of  0.5‐  1.5x104/  cm2.  A supplement of 10‐20ng/ml of b‐FGF (PeproTech, TebuBio) in the medium used for the replating  step  improved  cell  viability.  Media  was  then  changed  every  3‐4  days  and monolayer cultures were kept under differentiation for up to 21 days.  
DNA Transfections ES Hdhex4­5  cells were plated  in self renewal conditions at a density 1‐1.5*104/cm2 and transfected  after  24  hours with different  expression  vector  using  Lipofectamine  2000 (Invitrogen,  Carlsbad,  CA,  USA).  To  produce  stable  cell  lines  expressing  N‐terminal 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fragment  of  huntingtin  after  24  hours  from  lipofection  cells  were  selected  with puromycin  (2  µg/ml)  for 15  days.  Puromycin‐resistant  clones were  collected.  RT‐PCR was performed to analyze the presence of the transgene and the protein was assayed by Western blotting.  
 
Constructs The  cDNA  of  the  N‐terminal  part  of  huntingtin  from  different  species were  cloned  in pCAG expression vector  carrying an  IRES element and a puromycin resistance  cassett. The  constructs  product  are:  pCAGDdN‐500‐HA,  pCAGspN‐519‐HA,  pCAGmmN‐548, pCAGmmN‐548‐HA,  pCAGhs‐N652‐15Q,  pCAGhsN‐652‐128Q,  pCAGmmC‐500 (respectively  carryng  the  N‐terminal  portion  of  Dictyostelium  discoideum, Strongylocentrotus  purpuratus,  Mus  musculus,  Homo  sapiens).  Constructs  with huntingtin from Dictyostelium, Strongylocentrotus are tagged with HA (hemagglutinin) tag.  The  N‐terminal  portion  of  Dyctyostelium  huntingtin  was  provided  by  Professor James Gusella  (Massachusetts General Hospital, Boston). 3xFLAG 7Q  full‐lenght mouse huntingtin  was  kindly  provided  by  Scott  Zeitlin’s  laboratory,  University  of  Virginia School of Medicine. Other  constructs using  for  transfection:  pCAG­Ncadherin­wt,  pCAG­
Ncadherin­GDmutant,  carrying  respectively  cDNA  of  murine  N‐cadherin  in  wild‐type form and mutated on ADAM‐10 cleavage site (Uemura et al…) 
 





Immunofluorescence Cells were  fixed  in 4% paraformaldehyde  for 15 min at  room  temperature. Cells were permeabilized  in PBS 1X‐0.5% Triton X‐100 and blocked with 5% Fetal Calf Serum for 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1 h.  Primary  antibodies were  diluted  in  blocking  buffer  and  applied  overnight  at  4°C. After  3  washes  in  PBS,  appropriate  secondary  antibodies  conjugated  to  Alexa fluorophores  488  or  568  (Molecular  Probes,  Invitrogen  Carlsbad,  CA,  USA)  1:500  in blocking solution were applied for 1 h at room temperature. Cells were incubated for 10 minutes with  Hoechst  33258  (5 μg/ml; Molecular  Probes,  Invitrogen).  The  cells were then  washed  twice  in  PBS  buffer.  Images  were  acquired  with  a  Leica  DMI  6000B microscope (with LAS‐AF imaging software) and then processed with Adobe Photoshop and ImageJ software. 
 






Antibodies used for Western blotting and immunocytochemistry Monoclonal anti‐HA Covance (IF 1:500; WB 1:1000);  Monoclonal anti‐Huntingtin Mab2166 Millipore (IF 1:800; WB 1:2000);   Monoclonal anti‐MAP2 Becton Dickinson (IF 1:1000);  Monoclonal anti‐N‐cadherin Becton Dickinson (IF 1:1000; WB 1:4000);  Monoclonal anti‐Nestin Millipore (IF 1:200; WB 1:1000);  Monoclonal anti‐OCT4 Santa Cruz (IF 1:100);  Monoclonal anti‐Tubulin Sigma (WB 1:3000);  Polyclonal  anti‐ADAM‐10  (kindly  provided  by  Paul  Saftig  lab  at  the  University  of  Kiel) (WB 1:1000);  Polyclonal anti‐GFAP Dako (IF 1:1000);  Polyclonal anti‐ZO‐1 Zymed (IF 1:50).  
RNA extraction and reverse transcription Total RNA was extracted  from cells  in  self‐renewal  condition or during differentiation protocol with Trizol reagent (Invitrogen, Carlsbad, CA, USA). Pellets containing 2‐5x106 cells were lysate in 1 mL of Trizol reagent. Clorophorm was added 200 µL/mL of Trizol. Samples  were  vortexed  vigorously  for  15  seconds  and  centrifuged  at  9.000×g  for  15 minutes at 4°C. Following centrifugation, the mixture separates into lower red, phenol‐ chloroform  phase,  an  interphase,  and  a  colorless  upper  aqueous  phase.  The  aqueous phase,  containing  RNA  was  transferred  into  fresh  tube.  One  volume  of  2‐Propanolol (SIGMA) was  added  and RNA was  precipitated  at  12.000×g  for  30‐40 minutes  at  4°C. Removed  the  supernatant  completely,  the pellets was washed once with 1 mL of 75% ethanol.  Samples  were  centrifuged  at  12.000×g  for  10  minutes.  Pellets  were resuspended  in  an  appropriate  volume  of  ultra‐pure  water  (SIGMA).  Total  RNA concentration  was  measured  with  a  NanoDrop  1000  Spectrophotometer  (Thermo Scientific, Waltham, MA, USA). To detect mRNA levels, 1000 ng of total RNA was reverse‐transcribed to single‐stranded cDNA with Superscript reverse transcriptase (Invitrogen, Carlsbad, CA, USA) 1U/reaction and random primers 250 ng. 
 
Real­time PCR  We used an iCycler Thermal Cycler with a Multicolour Real‐time PCR Detection System (Bio‐Rad, Hercules, CA, USA). All  reactions were performed  in a  total  volume of 25 µL that  contained  5  µl  of  cDNA,  50 mM KCl,  20 mM Tris‐HCI,  pH 8.4,  0.2 mM dNTPs,  25 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units/mL iTaq DNA polymerase, 3 mM MgCl2, SYBR Green I with 10 nM fluorescein and stabilisers (iQTM SYBR Green Supermix‐Biorad, Hercules, CA, USA), and 0.3 mM each of forward and reverse primers. The amplification cycles consisted of an initial denaturing cycle at 95°C for 3 min, followed by 45 cycles of 30 s at 95°C, 30 s at 60°C, and 30 s at 72°C.  Fluorescence  was  quantified  during  the  60°C  annealing  step,  and  product formation was confirmed with a melting curve analysis (55°C–94°C). Primers sequence are:  ADAM‐10 Fw  GGAAGCTTTAGTCATGGGTCTG  ADAM‐10 Rev   CTCCTTCCTCTACTCCAGTCAT N‐Cadherin Fw   AACACAGCCACAGCCGTCATC  N‐cadherin Rev   CTTTGTCCGTGACAGTTAGGTTG  Huntingtin Fw   CGCTATGGAACTGTTTCTGCTGTG  Huntingtin Rev   CTGTAGCCTTGGAAGATTAGAATCCATC   
MTT Assay Cells were plated in triplicates into twenty‐four well plates (IWAKI,  Japan) at a density of 2x104/ well in supplemented GMEM as indicated above. After 12 hours incubation at 37oC,  medium  was  replaced  in  half  the  wells  with  serum‐deprived  medium (composition: GMEM supplemented as described above but without serum), and in the remaining half of the wells with fresh complete GMEM. All cells were then incubated at 37oC  for  the  following  time points 6, 12, 24, 36, 48 and 96 hours. At  each  time point, cells  were  exposed  to  3‐  [4.5‐dimethylthiazol‐2‐phenyl]‐2.5‐diphenyl‐tetrazolium bromide,  and mitochondrial  formazan  release was  quantified  at  560nm  using  a  plate reader (Bio‐Rad).   
Caspase­3 activity Assay For  each  tested  condition,  cells  were  plated  in  triplicates  in  a  96  well  plate  with transparent bottom (PBI) at a density of 5 000 cells/ well. After 36 hours incubation at 37oC, half wells received 100μl of freshly prepared complete GMEM and the other half 100μl GMEM lacking serum. After 3 hours incubation, 20μl of Cell Titer‐Blue ® Reagent (Cell Titer‐Blue ® Assay‐ Promega) was added to each well and plates were incubated for another 3 hours at 37oC. Fluorescence was recorded at 550/595nm (plate reader‐ 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Figure 1. Huntingtin aminoacid primary sequence: schematic representation ofhuntingin  primary  aminoacid  sequence  and  the  relative  aminoacid  sites  andconsensa known of protein.
Figure 2. Huntingtin function during the lifetime
Figure  3.  The  evolution  of  polyQ:  A)  N‐terminal  portion  of  the  wide‐rangingmultialignment  of  18  huntingtin  homologues.  PolyQ  appears  in  echinoderm
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Figure  7.  Schematic  representation  of  monolayer  neural  differentiation






















Figure 8 . “Rosetteless phenotype” in absence of huntingtin: Immunocytochemistryanalysis  at  day  8  of  neural  differentiation  protocol  in  two  different  batches  ofhuntingtin  depleted  cells  (Hdhex4/5  and  Hdhpr­ex1)  and  their  wild‐type  counterpart(Hdh+/+ and Hdh+/+*).   Cells are  immunodecorated with Nestin, N‐cadherin and ZO‐1markers.
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Figure  13.  Migration  analysis  of  huntingtin  knock  out  cells  during  neural
differentiation:  Migration  analysis  by  microscope  time  lapse.  Quanti]ication  ofmotility speed of the cells (um/min) during differentiation from day 2 to day 8.
Figure 14. N­cadherin analysis during differentiation: A) mRNA level of N-cadherin
by Real time PCR; B) Immunoblotting  for  full‐length  N‐cadherin  and  CTF‐1,  duringneural  differentiation  (D0,  D5,  D6,  D7,  D8)  on  total  protein  lysates  from Hdh+/+  and
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Figure  17.  Silencing  of  ADAM­10  in  Hdhex4/5cells  :  A)  ADAM‐10  knock‐down  in
Hdhex4/5 cells. Immunostaining for Nestin at D8 of the monolayer protocol is shown. B)Immunoblotting for N‐cadherin and CTF1 at D8 of monolayer differentiation protocolin Hdhex4/5 knock‐down for ADAM‐10 and parental cells.
Figure 18. Schematic representation of phylogenetic tree. Homologues assayed for N-
terminal activity are highlighted in red box Homo sapiens, Mus musculus,
























Figure 19. Characterization of  ES Hdh4/5 stably  expressing N­terminal  huntingtin
from different  species:  Immunocytochemistry  A)  and  immunoblotting B)  to  detecttransgene  expression  in  stable  cell  lines.  Cell  lines  produced  express  the N‐terminalportion from Hs Homo sapiens; Mm Mus musculus; Sp Strongylocentrotus purpuratus;
Dd Dictyostelium discoideum.
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Figure  20.  The  ability  to  form  rosettes  is  N­terminal  huntingtin  function  :Immunocytochemistry  for  Nestin  at  D8  of  neural  differentiation  in  ES  Hdhex4/5stably expressing N‐terminal and C‐terminal portion of murine huntingtin.
Figure  21. The  ability  to  form  rosettes  is  a  function  evolved  in deuterostomes:A)Immunocytochemistry  for N‐cadherin at D8 of neural differentiation  in ES Hdhex4/5stably  expressing  N‐terminal  portion  of  huntingtin  from  Dictyostelium  discoideum,
Strongylocentrotus  purpuatus,  Mus  musculus  and  Homo  sapiens  and  Drosophila












































































Figure  22.  N­cadherin  cleavage  during  phylogenesis  and  rescue  of






































Figure  23.  Rosetteless  phenotype  in  the  presence  of  expanded  polyQ:  A)Immunocytochemistry  for  N‐cadherin  at  D8  of  neural  differentiation  in  ES  Hdhex4/5stably  expressing  N‐terminal  portion  of  human  huntingtin with  15Q  and  128Q.  B)  N‐cadherin  immunoblotting  with  detection  and  quanti]ication  C)  of  the  CTF‐1.  D)Immonostaining for neuronal markers GAP43 at D21 of neural differentiation.
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Figure 24 Anti­apoptotic activity is an ancestral huntingtin function: Caspase‐3 activity assay in all transgenic cell lines in self‐renewal condition.
